譜尼測試(300887.SZ):2020年淨利升30.91%至1.64億元 擬10轉8派5元
格隆匯3月18日丨譜尼測試(300887.SZ)披露2020年年度報吿,實現營業收入14.26億元,同比增長10.78%;歸屬於上市公司股東的淨利潤1.64億元,同比增長30.91%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.37億元,同比增長27.57%;基本每股收益2.590元,擬向全體股東每10股派發現金紅利5元(含税),以資本公積金向全體股東每10股轉增8股。
譜尼測試集團創立於2002年,集團總部位於北京,現已發展成為擁有逾6000餘名員工,由26個大型實驗基地及53家子公司,29家分公司組成的服務網絡遍佈全國的大型綜合性檢驗認證集團。
譜尼測試具備CMA、CNAS、食品複檢機構、CATL、CCC、DILAC等資質,具備醫療機構執業許可證、醫療器械生產許可證等。得到生態環境部、農業農村部、市場監督管理總局、國家衞健委、民航局等多個國家部委認可及授權,檢測報吿獲90多個國家和地區的公認。譜尼測試是北京市批准的生物醫藥類工程實驗室、北京市科委認定的工程技術研究中心、博士後科研工作站、譜尼醫學獲批成為北京市首批新冠病毒核酸檢測單位。
自2020年1月新冠疫情爆發以來,集團積極承擔疫情防控工作,開展口罩、防護服等醫療器械檢測及中藥、化藥、生物醫藥檢測,拓展醫學檢測業務,集團全資子公司譜尼醫學取得醫療機構執業許可證併入選北京市新冠病毒核酸檢驗機構,開展核酸檢測業務,集團2020年度經營業績較去年同期有所提升,報吿期內集團實現營業收入14.26億元,實現淨利潤1.64億元,2020年度集團服務客户超過8.5萬家。
.
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.